Professional Documents
Culture Documents
a David
G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear/Harvard Medical School,
Boston, MA, USA; b Department of Ophthalmic Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of
Established Facts
• Benign and malignant sebaceous cell tumors are both known to originate in the caruncle.
• These tumors typically grow in nests and lobules in the caruncular stroma.
• Sebaceous tumors arising from the surface non-keratinizing squamous epithelium of the epibulbar and
tarsal regions have been reported.
Novel Insights
• A caruncular sebaceous adenoma originated from the surface squamous epithelium which displayed
focal sebaceous cell differentiation.
• The pattern of growth was most unusual and consisted of multiple invaginated crypts with intervening
finger-like villi.
• Lateral lobular sebaceous lobules originated as outgrowths from the crypts and were mostly respon-
sible for the widening of the stroma between the crypts.
• p16 nuclear and cytoplasmic positivity indicated a possible causative role for high-risk human papil-
loma virus, while immunohistochemical results for intact mismatch nuclear repair proteins ruled out
an association with the Muir-Torre syndrome.
Keywords Abstract
Caruncle · Sebaceous adenoma · Villous feature · A 68-year-old woman developed an asymptomatic left ca-
Cytokeratins · Adipophilin · DNA mismatch repair protein · runcular multilobular lesion over one year. Excision of the
p16 · High-risk human papilloma viruses · Muir-Torre lesion displayed a benign sebaceous neoplasm taking origin
syndrome from the surface squamous epithelium which invaginated
into the stroma to create crypts resembling the conjunctival
pseudoglands of Henle or the glands of Lieberkuhn of the
c d
V
V V C
V V
V
C C V C C
C
e f
C
L L
C
L
L
L C
C
Fig. 1. Clinical and histopathologic features of the caruncular tu- rated by crypts (C), some of which are obliquely sectioned and only
mor. a A tumor completely replaces the right normal caruncle of partially delineated. There are lymphocytic collections adjacent to
a 48-year-old woman who developed the lesion over several the lobules (arrows). e On both sides of a crypt (C) and along its
months. b Higher-power clinical photograph of a knobby tumor entire length are lateral outpouchings of lobules with pale cells.
with many crevices between the units. c Excised specimen reveals The inset depicts a portion of the cryptal wall with a focal collec-
several thick finger-like villous units (V) separated by invagina- tion of amorphous eosinophilic material and degenerating cells
tions of surface epithelium to create crypts (C) in a cup-like fashion and holocrine secretion. f Apical pore region of a crypt (C) is pres-
of inverted growth. The crypts contain eosinophilic holocrine se- ent next to lobules (L) of tumor originating in this area from the
cretions and generate nearby lobules. The arrow indicates a lym- surface epithelium rather than from a cryptal wall. b–f Hematoxy-
phoid aggregate. d Another field with more villous units (V) sepa- lin and eosin; c, d ×2; e ×4; inset ×40; f ×10.
Immunohistochemical Findings cytes) by virtue of exhibiting vesicular positivity for the presence
of endogenously synthetized lipid (Fig. 1f). p16 was strongly posi-
Cytokeratin (CK) 14 stained the surface epithelium and the full tive in the nuclei and cytoplasm of the surface epithelium, the
thickness of all of the cryptal and lobular elements of the lesion cryptal structures, and portions of the sebaceous lobules (Fig. 3a,
(Fig. 2c). CK7 revealed a similar staining pattern except that the b), suggesting an association of the tumor with high-risk HPV. p53
centers of the lobules were more weakly staining (Fig. 2d). Cam 5.2 was negative in all cells. Ki-67 was positive in 20–40% of the basa-
stained only the surface epithelium and the basaloid cells in the loid cells depending on the size of the lobule, but predominantly
lobules. Nuclear androgen receptors were identified in the vacu- negative in the centers of the lobules (Fig. 2f, inset). Testing for
olated cells (Fig. 1e). While CD163 was negative, adipophilin stain- DNA MMR protein expression was intact for MLH1, MSH2,
ing confirmed that the vacuolated lobular, cryptal, and surface ep- PMS2, and MSH6 (Fig. 3c–f, respectively), thereby failing to im-
ithelial clear or vacuolated cells were sebaceous in nature (sebo- plicate a possible association with the Muir-Torre syndrome.
L L
c d
L C
C C P
L
L
L
e f
Fig. 2. Additional histopathologic features and results of immuno- e Androgen receptor positivity is identified in the tumor cell nu-
histochemical stains. a Clear cells involve the conjunctival epithe- clei, a usual finding in sebaceous cells. f Adipophilin stains the
lium (arrow), which also forms lobules (L). b Highly vacuolated vacuoles in the sebaceous tumor cells. The staining has a vesicular
cells with central vesicular nuclei in the absence of mitoses repre- form with central clearance, a characteristic of endogenously syn-
sent sebaceous cells (sebocytes). c Cytokeratin (CK) 14 uniformly thetized cytoplasmic lipid. The inset shows Ki-67 nuclear positiv-
stains the surface conjunctival epithelium (arrows), the sebaceous ity mostly seen among the basal cells, while the central lobular cells
lobules (L), and the lining of the crypts (C). P, surface pore at open- are only rarely positive. a, b Hematoxylin and eosin; a ×20; b ×40.
ing of crypt. d CK7 immunostains the crypts (C) and perimeters c–f Immunoperoxidase with diaminobenzidine and hematoxylin
of the lobules with weaker staining of the center of the lobules (L). counterstain; c ×4; d ×10; e ×20; inset ×40; f ×40.
c d
niceal regions of the conjunctival sac, they are called evincing follicular organization, as well as pools of eo-
pseudoglands of Henle [3, 4, 18, 19]. These structures are sinophilic holocrine secretions that expanded the dead-
apt to be seen in the forniceal and tarsal conjunctiva with end luminal bases of the crypts. The current lesion should
varying depths of the invaginations into the stroma; on be distinguished from inverted squamous papilloma and
the other hand, the epibulbar and caruncular epithelium dacryoadenoma [21–24].
tends to be spared from the formation of these pseudog- The ability of mature, fully differentiated conjunctival
lands. In the present caruncular lesion, the unusual tubu- epithelium to spawn benign and malignant sebaceous tu-
lar downgrowths of surface epithelium imitated more mors is consistent with its embryologic role in providing
closely the appearance of the crypts of Lieberkuhn of the sebaceous glands and vellus hairs for the caruncle. A latent
bowel [20] in that the crypts alternated with thickened or capacity to undergo sebaceous differentiation obviously
widened villi. This pattern is different from that of an exo- must persist into adulthood, as exemplified by the current
phytic papilloma, which features thin or delicate, out- lesion and previous reports of “ectopic” epibulbar and tar-
wardly projecting fibrovascular fronds. However, rare in- sal sebaceous tumors [5–14]. The multipotentiality of the
verted conjunctival squamous papillomas have been en- conjunctival epithelium is also exemplified by an epibul-
countered [21–23]. In addition to the neoplastic sebaceous bar dacryoadenoma [24]. Again, one should recall that the
lobules, the present wide villi were the consequence of major and accessory lacrimal glands are also outgrowths
prominent stromal aggregates of lymphocytes sometimes of the embryonic conjunctival epithelium [25].
References
1 Boniuk M, Zimmerman LE. Sebaceous car- 6 Meier-Gibbons F, Messmer E. Sebaceous 11 Kiratli H, Poyraz C, Gököz A. Sebaceous ad-
cinoma of the eyelid, eyebrow, caruncle and gland adenoma of the palpebral conjunctiva enoma of the bulbar conjunctiva in associa-
orbit. Int Ophthalmol Clin. 1972; 12(1): 225– in a patient with Muir-Torre-syndrome: a tion with glioblastoma multiforme and
57. case report. Graefes Arch Clin Exp Ophthal- chronic lymphocytic leukemia. Cornea. 2007
2 Straatsma BR. Meibomian gland tumors. mol. 1994 Dec;232(12):734–6. Oct;26(9):1136–7.
AMA Arch Opthalmol. 1956 Jul;56(1):71–93. 7 Margo CE, Grossniklaus HE. Intraepithelial 12 Tok L, Tok OY, Argun M, Ciris IM, Baspinar
3 Jakobiec FA, Iwamoto T. The ocular adnexa: sebaceous neoplasia without underlying inva- S, Gunes A. Corneal limbal sebaceous adeno-
Lids, conjunctiva and orbit. In: Fine BS, Ya- sive carcinoma. Surv Ophthalmol. 1995 Jan- ma. Cornea. 2014 Apr;33(4):425–7.
noff M, editors. Ocular Histology: A Text and Feb;39(4):293–301. 13 Ilhan HD, Turkoglu EB, Bilgin AB, Bassorgun
Atlas. 2nd edition ed. Maryland: Harper and 8 Honavar SG, Shields CL, Maus M, Shields JA, I, Dogan ME, Unal M. A unique case of iso-
Row, Hagerstown; 1979. p. 289–342. Demirci H, Eagle RC Jr. Primary intraepithe- lated sebaceous adenoma of the bulbar con-
4 Bron AJ, Tripathi RC, Tripathi BJ. The ocular lial sebaceous gland carcinoma of the palpe- junctiva. Arq Bras Oftalmol. 2016 Jul-Aug;
appendages: Eyelids, conjunctiva and lacri- bral conjunctiva. Arch Ophthalmol. 2001 79(4):253–4.
mal apparatus. Wolff’s Anatomy of the Eye May;119(5):764–7. 14 Spraul CW, Jakobczyk-Zmija MJ, Lang GK.
and Orbit. 8th ed. London: Chapman and 9 Rishi K, Font RL. Sebaceous gland tumors of [Sebaceous hyperplasia of the lower eyelid].
Hall Medical; 1997. pp. 30–49. the eyelids and conjunctiva in the Muir-Torre Klin Monatsbl Augenheilkd. 1999 Nov;
5 Jakobiec FA, Zimmerman LE, La Piana F, syndrome: a clinicopathologic study of five 215(5):319–20.
Hornblass A, Breffeilh RA, Lackey JK. Unusu- cases and literature review. Ophthal Plast Re- 15 Jakobiec FA. Sebaceous adenoma of the eyelid
al eyelid tumors with sebaceous differentia- constr Surg. 2004 Jan;20(1):31–6. and visceral malignancy. Am J Ophthalmol.
tion in the Muir-Torre syndrome. Rapid clin- 10 Font RL, Rishi K. Sebaceous gland adenoma 1974 Dec;78(6):952–60.
ical regrowth and frank squamous transfor- of the tarsal conjunctiva in a patient with 16 Yonekawa Y, Jakobiec FA, Zakka FR, Fay A.
mation after biopsy. Ophthalmology. 1988 Muir-Torre syndrome. Ophthalmology. 2003 Sebaceoma of the eyelid. Ophthalmology.
Nov;95(11):1543–8. Sep;110(9):1833–6. 2012 Dec;119(12):2645.e1–4.